Does FUTIBATINIB Cause Decreased appetite? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Decreased appetite have been filed in association with FUTIBATINIB (LYTGOBI). This represents 7.5% of all adverse event reports for FUTIBATINIB.
12
Reports of Decreased appetite with FUTIBATINIB
7.5%
of all FUTIBATINIB reports
1
Deaths
7
Hospitalizations
How Dangerous Is Decreased appetite From FUTIBATINIB?
Of the 12 reports, 1 (8.3%) resulted in death, 7 (58.3%) required hospitalization.
Is Decreased appetite Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FUTIBATINIB. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does FUTIBATINIB Cause?
Death (30)
Diarrhoea (29)
Hyperphosphataemia (22)
Nausea (21)
Disease progression (20)
Dry mouth (18)
Fatigue (18)
Off label use (16)
Vomiting (15)
Dry eye (13)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which FUTIBATINIB Alternatives Have Lower Decreased appetite Risk?
FUTIBATINIB vs GABAPENTIN
FUTIBATINIB vs GABAPENTIN ENACARBIL
FUTIBATINIB vs GADAVIST
FUTIBATINIB vs GADOBENATE DIMEGLUMINE
FUTIBATINIB vs GADOBUTROL